🚨 A $200 test could prevent 1,300+ U.S. chemo deaths each year.
DPYD screening flags patients who can’t tolerate chemo; 90%+ of severe reactions avoided.
Required in Europe.
Yet, optional here...
👉 Follow @sbokhiria.bsky.social
#Oncology #PrecisionMedicine #DPYD #Chemo
Don’t miss My Gene Counsel CEO Ellen Matloff on the latest Oncology Revolution podcast discussing genomics, genetic counseling, and digital tools shaping cancer care. Listen on any podcast platform. #genechat #precisionmedicine #DPYD #precisiononcology
1/1 Did you know that the #PharmVar 'Allele Details' page now shows Activity Values for #CYP2D6, #CYP2C9 and #DPYD in addition to CPIC function and also provides links to easily look up allele frequencies?
🧬 Prevent 5 FU chemotherapy toxicity with DPYD genetic testing
🔗 Visit our website to learn more about how DPYD testing can enhance treatment decisions and improve patient safety genseqgroup.com/services/cli...
#DPYD #Pharmacogenetics #GeneticTesting #OncologyCare #CancerTreatment #genetics
NCCN’s 2025 Colon Cancer Guidelines now support DPYD genotyping before fluoropyrimidine chemotherapy.
Pharmacists are key to enacting this guideline through leading testing efforts and educating patients on their options.
shorturl.at/t3qT7
#Pharmacogenetics #DPYD #NCCN #PrecisionMedicine
Come visit us at stand X7 at #Biomedica today! We had a brilliant time yesterday and we're looking forward to the day ahead. We hope to see you there.
#Biomedica2025 #Genseq #Cardiology #singlegenetests #DPYD #TPMT #HFE #TTR #CYP2C19 #Conventioncentredublin #oncology #cardiology#DNA #RNA
Genseq is delighted to launch our Single Gene Testing service SoloSEQ!🎉 To find out more go to our website 💻 lnkd.in/eSqasvaJ or email us at
support@genseqgroup.com
#singlegenetesting #singlegenetests #DPYD #TPMT #CYP2C19 #HFE #TTR #singlegenetestingservice #ISO15189 #ISO15189accredited #DNA #RNA
PGx testing in oncology: In the PREPARE trial (563 patients), actionable genotypes led to a 90% drop in toxic effects, fewer hospitalizations, and lower management costs without reducing treatment intensity or 3-year survival. Time to act!
#Pharmacogenomics #Oncology #DPYD #UGT1A1 #TPMT #NUDT15